The Stock Exchange of Hong Kong (HKEX) has issued a Statement of Disciplinary Action against two former directors of China Health Technology (HKG:1069), according to its Wednesday bourse filing.
The duo namely Wang Yue, a former executive director, and Tian Guangmei, a former independent non-executive director, have been censured and deemed unsuitable to hold director or senior management positions.
This Director Unsuitability Statement signifies HKEX's opinion that the two are unfit for such roles within the company or its subsidiaries.
The Listing Committee found Mr. Wang breached Rule 3.08 regarding certain loans, while both Mr. Wang and Ms. Tian breached rules by failing to cooperate in the Division's investigation concerning a disposal.
Their actions were deemed a serious failure to discharge their responsibilities under the Listing Rules. It is clarified that these sanctions apply solely to the two named former directors.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.